HomeGrants › PAR-27-105

Forecasted

National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)

Federal funding opportunity PAR-27-105 from National Institutes of Health.

View forecast on Grants.gov →Forecasted — not yet open

Posted
June 9, 2026
Closes
See announcement
Cost sharing
No
Instrument
Grant
Assistance listing
93.286
Category
Health

Program funding history

Awards made under Assistance Listing 93.286 across FY2024–FY2026, from public federal spending records.

FY2024 obligated
$343.8M
FY2025 obligated
$339.6M
FY2026 (to date) obligated
$179.4M
Awards in window
2,126

Top recipients: The General Hospital Corporation, The Johns Hopkins University, Brigham & Womens Hospital Inc, University of California, Davis, Trustees of the University of Pennsylvania, the

Source: USAspending.gov · refreshed July 2026

Synopsis

This Notice of Funding Opportunity (NOFO) encourages grant applications for National Centers for Biomedical Imaging and Bioengineering (NCBIB). NCBIB are national resource centers for conducting research and development on new technologies that are driven by the needs of basic, translational, and/or clinical researchers. NCBIB also make their technologies available to other investigators, train members of the research community in the use of the technologies and disseminate the technologies broadly.

Who can apply

Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Foreign InstitutionsNon-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed.Number of ApplicationsApplicant organizations may submit more than one application, provided that each application is scientifically distinct.NIH will not accept duplicate or highly overlapping applications under review at the same time per NIH Grants Policy Statement Section 2.3.7.4 Submission of Resubmission Application. This means that the NIH will not accept:A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application.A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.An application that has substantial overlap with another application pending appeal of initial peer review (see NIH Grants Policy Statement 2.3.9.4 Similar, Essentially Identical, or Identical Applications).Renewals: Applicants may submit a Renewal application. However, NIBIB NCBIB Awards will be restricted to a total of fifteen years.

How to apply

Applications go through the official government listing. Grants Radar links you straight to the source.

View on Grants.gov

Agency contact: NIBIB P41 Director · NIBIB_P41@nih.gov · 2402717701

Get grants like this every Tuesday — free

One email a week: the biggest new federal grants and what’s closing soon. Unsubscribe in one click.

The free edition carries one clearly labeled sponsor slot. No spam, ever. Privacy

Similar grants

Never miss a funding deadline again

Grants Radar sends AI-enriched alerts on federal grants and contracts matched to what you do. Founding seats are limited and locked for life.

Get funding alerts